145 related articles for article (PubMed ID: 29667531)
1. Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV?
Tsima B; Ratcliffe SJ; Schnoll R; Frank I; Kolson DL; Gross R
J Int Assoc Provid AIDS Care; 2018; 17():2325958218768018. PubMed ID: 29667531
[TBL] [Abstract][Full Text] [Related]
2. The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV.
Harrison JD; Dochney JA; Blazekovic S; Leone F; Metzger D; Frank I; Gross R; Hole A; Mounzer K; Siegel S; Schnoll RA; Ashare RL
J Neurovirol; 2017 Aug; 23(4):550-557. PubMed ID: 28429289
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Associated Factors of Neurocognitive Impairment in HIV-Positive Patients on Effective Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Treatment.
Giancola ML; Balestra P; Ammassari A; Ricottini M; Lorenzini P; Angeletti C; Bellagamba R; Tommasi C; Tempestilli M; Zaccarelli M; Pinnetti C; Gallo AL; Antinori A; Narciso P; Nicastri E
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):907-908. PubMed ID: 29929374
[No Abstract] [Full Text] [Related]
4. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
Kallianpur AR; Wang Q; Jia P; Hulgan T; Zhao Z; Letendre SL; Ellis RJ; Heaton RK; Franklin DR; Barnholtz-Sloan J; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Grant I;
J Infect Dis; 2016 Apr; 213(7):1065-73. PubMed ID: 26690344
[TBL] [Abstract][Full Text] [Related]
5. Frequency and Correlates of Subjective Cognitive Impairment in HIV Disease.
Sheppard DP; Woods SP; Massman PJ; Gilbert PE
AIDS Behav; 2019 Mar; 23(3):617-626. PubMed ID: 30311103
[TBL] [Abstract][Full Text] [Related]
6. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.
Ciccarelli N; Fabbiani M; Di Giambenedetto S; Fanti I; Baldonero E; Bracciale L; Tamburrini E; Cauda R; De Luca A; Silveri MC
Neurology; 2011 Apr; 76(16):1403-9. PubMed ID: 21502598
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility.
Fabbiani M; Grima P; Milanini B; Mondi A; Baldonero E; Ciccarelli N; Cauda R; Silveri MC; De Luca A; Di Giambenedetto S
Antivir Ther; 2015; 20(4):441-7. PubMed ID: 25516553
[TBL] [Abstract][Full Text] [Related]
9. Chronic Tobacco-Smoking on Psychopathological Symptoms, Impulsivity and Cognitive Deficits in HIV-Infected Individuals.
Chang L; Lim A; Lau E; Alicata D
J Neuroimmune Pharmacol; 2017 Sep; 12(3):389-401. PubMed ID: 28303534
[TBL] [Abstract][Full Text] [Related]
10. Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population.
Ciccarelli N; Baldonero E; Milanini B; Fabbiani M; Cauda R; Di Giambenedetto S; Silveri MC
Infez Med; 2019 Sep; 27(3):274-282. PubMed ID: 31545771
[TBL] [Abstract][Full Text] [Related]
11. Lifetime antiretroviral exposure and neurocognitive impairment in HIV.
Amusan P; Power C; Gill MJ; Gomez D; Johnson E; Rubin LH; Fujiwara E
J Neurovirol; 2020 Oct; 26(5):743-753. PubMed ID: 32720232
[TBL] [Abstract][Full Text] [Related]
12. [Neurocognitive impairments of HIV infected individuals -- preliminary results of a national prevalence study in Hungary].
Lakatos B; Szabó Z; Bozzai B; Bánhegyi D; Gazdag G
Ideggyogy Sz; 2014 Nov; 67(11-12):409-14. PubMed ID: 25720243
[TBL] [Abstract][Full Text] [Related]
13. Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals.
Kalayjian RC; Wu K; Evans S; Clifford DB; Pallaki M; Currier JS; Smryzynski M
J Acquir Immune Defic Syndr; 2014 Sep; 67(1):30-5. PubMed ID: 25118793
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation.
Eckard AR; Rosebush JC; O'Riordan MA; Graves CC; Alexander A; Grover AK; Lee ST; Habib JG; Ruff JH; Chahroudi A; McComsey GA
Antivir Ther; 2017; 22(8):669-680. PubMed ID: 28327462
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive Impairment in Well-Controlled HIV-Infected Patients: A Cross-Sectional Study.
Portilla I; Reus S; León R; van-der Hofstadt C; Sánchez J; López N; Boix V; Merino E; Portilla J
AIDS Res Hum Retroviruses; 2019 Jul; 35(7):634-641. PubMed ID: 30880401
[TBL] [Abstract][Full Text] [Related]
16. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment.
Tozzi V; Balestra P; Galgani S; Narciso P; Ferri F; Sebastiani G; D'Amato C; Affricano C; Pigorini F; Pau FM; De Felici A; Benedetto A
AIDS; 1999 Oct; 13(14):1889-97. PubMed ID: 10513647
[TBL] [Abstract][Full Text] [Related]
17. Human Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited Settings.
Robertson KR; Jiang H; Kumwenda J; Supparatpinyo K; Marra CM; Berzins B; Hakim J; Sacktor N; Campbell TB; Schouten J; Mollan K; Tripathy S; Kumarasamy N; La Rosa A; Santos B; Silva MT; Kanyama C; Firhnhaber C; Murphy R; Hall C; Marcus C; Naini L; Masih R; Hosseinipour MC; Mngqibisa R; Badal-Faesen S; Yosief S; Vecchio A; Nair A;
Clin Infect Dis; 2019 May; 68(10):1733-1738. PubMed ID: 30219843
[TBL] [Abstract][Full Text] [Related]
18. Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.
Coban H; Robertson K; Smurzynski M; Krishnan S; Wu K; Bosch RJ; Collier AC; Ellis RJ
AIDS; 2017 Jul; 31(11):1565-1571. PubMed ID: 28471765
[TBL] [Abstract][Full Text] [Related]
19. Machine learning models reveal neurocognitive impairment type and prevalence are associated with distinct variables in HIV/AIDS.
Tu W; Chen PA; Koenig N; Gomez D; Fujiwara E; Gill MJ; Kong L; Power C
J Neurovirol; 2020 Feb; 26(1):41-51. PubMed ID: 31520320
[TBL] [Abstract][Full Text] [Related]
20. Development of a neurocognitive test battery for HIV-associated neurocognitive disorder (HAND) screening: suggested solutions for resource-limited clinical settings.
Chan LG; Ho MJ; Lin YC; Ong Y; Wong CS
AIDS Res Ther; 2019 Apr; 16(1):9. PubMed ID: 30987670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
